Search

everythinglearnresearchcommunity

for

Search:↓

High levels of 3 alpha-diol glucuronide in the blood are a marker of increased androgen action in women with excessive hair growth of unknown cause.

Finasteride effectively reduces hair loss by decreasing androgen levels.

Certain gene variations in AKT2 are more common in women with PCOS and are linked to higher levels of specific hormones and symptoms.

PSA levels are higher in women with PCOS, but FAI is a more accurate marker for diagnosis.

Dehydroepiandrosterone (DHEA) is a prohormone important for producing sex steroids and has potential health benefits.

Measuring androstanediol glucuronide in blood is useful for assessing and tracking treatment in women with excessive hair growth.

People with hair loss may have different levels of certain hormones due to changes in hormone processing.

Men using hair loss drugs like finasteride may experience sexual side effects like erectile dysfunction, but it's unclear who will be affected and when. Treating depression and sexual symptoms is suggested, as these men often have higher rates of both. More research is needed to understand why these side effects occur.

ADT-G may be a useful indicator of increased androgen levels in women with acne and can be lowered with certain birth control pills.

Understanding how DHT works is important for diagnosing and treating hormone-related disorders.

Birth control pills can help reduce mild to moderate acne in women.

Creating stronger blockers for skin enzymes might lead to better treatment for conditions like acne and excessive hair growth.

Finasteride can have lasting negative effects on brain function and behavior by disrupting neurosteroid production.

Hair loss in women can be slowed with treatment, but more research needed for better solutions.

Different species and human skin models vary in their skin enzyme activities, with pig skin and some models closely matching human skin, useful for safety assessments and understanding the skin's protective roles.

The document concludes that blocking the internal pathways that create androgens might help treat cancers that depend on sex hormones.

The document concludes that treating female hair loss should target reducing excess androgen and blocking its effects on hair follicles, with the best treatments being hormonal therapy, adrenal suppression, and topical minoxidil.

Low-dose finasteride reduces excessive hair growth in teenage girls safely and affordably.

Baldness in men with prostate cancer is linked to higher levels of certain sex hormones, but chest hair density is not.

3α, 17β-androstanediol-glucuronide is not a useful marker for androgen excess but may help monitor certain treatments.

Androstanediol glucuronide is a reliable marker for hirsutism in women.

Testosterone and dihydrotestosterone play a role in women's health issues like excess hair and baldness, and treatments blocking these hormones may help.

Androgen conjugates might be better indicators of skin sensitivity to hormones in women with excessive hair growth.

Taking 5-Alpha Reductase Inhibitors before bladder removal surgery might make high-grade bladder tumors less aggressive.

5α reductase type 2 enzyme mutation and oxidative stress may increase androgenetic alopecia risk in Egyptians.

The document concludes that more research is needed to understand excessive hair growth in women with normal hormone levels and regular ovulation.

17α-estradiol is a safe estrogen that might protect the brain and doesn't cause feminization, needing more research for treating brain diseases.

Gene variant linked to prostate cancer, hormone levels, and hair loss.

Testosterone therapy can help improve mood, sexual function, and bone health in women with low androgen levels, but more research is needed to establish safe and effective guidelines.

Androgens play a role in female sexual function, and testosterone therapy can help women with low sexual desire, but more research is needed on treatments and long-term safety.